Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction
- PMID: 16632551
- DOI: 10.1152/ajpheart.01175.2005
Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction
Abstract
NF-kappaB is a key transcription factor that regulates inflammatory processes. In the present study, we tested the hypothesis that blockade of NF-kappaB ameliorates cardiac remodeling and failure after myocardial infarction (MI). Knockout mice with targeted disruption of the p50 subunit of NF-kappaB (KO) were used to block the activation of NF-kappaB. MI was induced by ligation of the left coronary artery in male KO and age-matched wild-type (WT) mice. NF-kappaB was activated in noninfarct as well as infarct myocardium in WT+MI mice, while the activity was completely abolished in KO mice. Blockade of NF-kappaB significantly reduced early ventricular rupture after MI and improved survival by ameliorating congestive heart failure. Echocardiographic and pressure measurements revealed that left ventricular fractional shortening and maximum rate of rise of left ventricular pressure were significantly increased and end-diastolic pressure was significantly decreased in KO+MI mice compared with WT+MI mice. Histological analysis demonstrated significant suppression of myocyte hypertrophy as well as interstitial fibrosis in the noninfarct myocardium of KO+MI mice. Blockade of NF-kappaB did not ameliorate expression of proinflammatory cytokines in infarct or noninfarct myocardium. In contrast, phosphorylation of c-Jun NH2-terminal kinase was almost completely abolished in KO+MI mice. The present study demonstrates that targeted disruption of the p50 subunit of NF-kappaB reduces ventricular rupture as well as improves cardiac function and survival after MI. Blockade of NF-kappaB might be a new therapeutic strategy to attenuate cardiac remodeling and failure after MI.
Similar articles
-
Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy.Cardiovasc Res. 2005 Jun 1;66(3):520-9. doi: 10.1016/j.cardiores.2005.02.007. Cardiovasc Res. 2005. PMID: 15914117
-
Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II.Cardiovasc Res. 2005 Sep 1;67(4):689-98. doi: 10.1016/j.cardiores.2005.04.030. Cardiovasc Res. 2005. PMID: 15921667
-
Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction.FASEB J. 2006 Sep;20(11):1918-20. doi: 10.1096/fj.05-5133fje. Epub 2006 Jul 12. FASEB J. 2006. PMID: 16837548
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
The paradoxical role of inflammation in cardiac repair and regeneration.J Cardiovasc Transl Res. 2010 Aug;3(4):410-6. doi: 10.1007/s12265-010-9193-7. Epub 2010 May 7. J Cardiovasc Transl Res. 2010. PMID: 20559773 Review.
Cited by
-
N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats.Clin Sci (Lond). 2014 Jan 1;126(1):85-94. doi: 10.1042/CS20120619. Clin Sci (Lond). 2014. PMID: 23834332 Free PMC article.
-
Caffeoylquinic Acid Derivatives Extract of Erigeron multiradiatus Alleviated Acute Myocardial Ischemia Reperfusion Injury in Rats through Inhibiting NF-KappaB and JNK Activations.Mediators Inflamm. 2016;2016:7961940. doi: 10.1155/2016/7961940. Epub 2016 Jul 19. Mediators Inflamm. 2016. PMID: 27516722 Free PMC article.
-
Fucoidan⁻Fucoxanthin Ameliorated Cardiac Function via IRS1/GRB2/ SOS1, GSK3β/CREB Pathways and Metabolic Pathways in Senescent Mice.Mar Drugs. 2019 Jan 21;17(1):69. doi: 10.3390/md17010069. Mar Drugs. 2019. PMID: 30669571 Free PMC article.
-
Aib1 deficiency exacerbates inflammatory responses in acute myocardial infarction mice.J Mol Med (Berl). 2022 Aug;100(8):1181-1190. doi: 10.1007/s00109-022-02231-1. Epub 2022 Jul 15. J Mol Med (Berl). 2022. PMID: 35840741
-
Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.Int J Clin Exp Pathol. 2015 Jan 1;8(1):530-40. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25755743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous